£4 Million Boost Expands Psychological Support at London’s Major Trauma Centres
NHS England has announced a significant expansion of psychological support services across London's four major trauma centres. This initiative aims...
Filter:
MHRA Warns of Increased Risk from Overuse of Blue Inhalers
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder to asthma patients about the dangers of overusing...
British Hospitals Introduce Rapid Titration for Heart Failure, Reducing Mortality by 62%
Hospitals across Britain are adopting a new approach to treating heart failure, known as rapid titration, which involves giving patients...
NHS Expands Cancer Vaccine Launch Pad to Include Melanoma Trial
NHS England has expanded its Cancer Vaccine Launch Pad to include a new trial of the iSCIB1+ vaccine for advanced...
GPs to Begin Prescribing Mounjaro for Prioritised Patient Cohorts from Late June
NHS England has announced that general practitioners will commence prescribing Mounjaro (tirzepatide) for weight management from 23 June 2025. This...
NICE Draft Guideline Seeks to Standardise Rehabilitation for Long-Term Neurological Conditions
NICE has published a draft guideline intended to transform rehabilitation services for millions living with long-term neurological conditions in England....
NICE Approves First NHS Treatment for Advanced Hodgkin Lymphoma
NICE has recommended brentuximab vedotin (Adcetris) with chemotherapy for routine NHS use in adults with previously untreated advanced CD30-positive Hodgkin...
NHS England Updates Guidance on Inclisiran for Lipid Management and CVD Prevention
NHS England has updated its guidance on lipid management in cardiovascular disease (CVD) prevention, reaffirming the role of inclisiran as...
NHS England ADHD Taskforce Shares Update on Progress and Priorities
NHS England’s ADHD Taskforce has shared an update on its ongoing efforts to improve support and care for people with...
MHRA Grants World-First Approval for Trofolastat in Prostate Cancer Imaging
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the UK’s use of Trofolastat, a diagnostic imaging agent that...
First Daily Pill for Endometriosis Approved for NHS Use
The National Institute for Health and Care Excellence (NICE) has approved the first daily pill for endometriosis, relugolix-estradiol-norethisterone (Ryeqo), marking...
Second Consultation Launched on NHS Funding for Alzheimer’s Treatments
The National Institute for Health and Care Excellence (NICE) has launched a second public consultation regarding NHS funding for Alzheimer's...